1-6 of 6
rapamycin
Close
Sort by
Journal Articles

First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings

Clinical Trials & Observations
Margaret L. MacMillan, Keli L. Hippen, David H. McKenna, Diane Kadidlo, Darin Sumstad, Todd E. DeFor, Claudio G. Brunstein, Shernan G. Holtan, Jeffrey S. Miller, Erica D. Warlick, Daniel J. Weisdorf, John E. Wagner, Bruce R. Blazar
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1425–1436.
https://doi.org/10.1182/bloodadvances.2020003219
Published: 2021
Includes: Supplemental data
Journal Articles

A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation

Clinical Trials & Observations
Nelli Bejanyan, Joseph A. Pidala, Xuefeng Wang, Ram Thapa, Taiga Nishihori, Hany Elmariah, Aleksandr Lazaryan, Farhad Khimani, Marco L. Davila, Asmita Mishra, Rawan Faramand, Michael D. Jain, Leonel Ochoa, Lia Elena Perez, Hien Liu, Melissa Alsina, Mohamed A. Kharfan-Dabaja, Hugo Fernandez, Michael L. Nieder, Frederick L. Locke, Claudio Anasetti, Ernesto Ayala
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1154–1163.
https://doi.org/10.1182/bloodadvances.2020003779
Published: 2021
Journal Articles

Kinase inhibitors developed for treatment of hematologic malignancies: implications for immune modulation in COVID-19

Chaja F. Jacobs, Eric Eldering, Arnon P. Kater
Journal: Blood Advances
Blood Adv (2021) 5 (3): 913–925.
https://doi.org/10.1182/bloodadvances.2020003768
Published: 2021
Includes: Supplemental data
Journal Articles

Transient antibody targeting of CD45RC inhibits the development of graft-versus-host disease

Laetitia Boucault, Maria-Dolores Lopez Robles, Allan Thiolat, Séverine Bézie, Michael Schmueck-Henneresse, Cécile Braudeau, Nadège Vimond, Antoine Freuchet, Elodie Autrusseau, Frédéric Charlotte, Rabah Redjoul, Florence Beckerich, Mathieu Leclerc, Eliane Piaggio, Regis Josien, Hans-Dieter Volk, Sébastien Maury, José L. Cohen, Ignacio Anegon, Carole Guillonneau
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2501–2515.
https://doi.org/10.1182/bloodadvances.2020001688
Published: 2020
Includes: Supplemental data
Journal Articles

IL-2 enhances ex vivo–expanded regulatory T-cell persistence after adoptive transfer

Scott N. Furlan, Karnail Singh, Christina Lopez, Victor Tkachev, Daniel Joel Hunt, James Hibbard, Kayla M. Betz, Bruce R. Blazar, Cole Trapnell, Leslie S. Kean
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1594–1605.
https://doi.org/10.1182/bloodadvances.2019001248
Published: 2020
Includes: Supplemental data
Journal Articles

Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide

Clinical Trials & Observations
Yvette L. Kasamon, Richard F. Ambinder, Ephraim J. Fuchs, Marianna Zahurak, Gary L. Rosner, Javier Bolaños-Meade, Mark J. Levis, Douglas E. Gladstone, Carol Ann Huff, Lode J. Swinnen, William H. Matsui, Ivan Borrello, Robert A. Brodsky, Richard J. Jones, Leo Luznik
Journal: Blood Advances
Blood Adv (2017) 1 (4): 288–292.
https://doi.org/10.1182/bloodadvances.2016002766
Published: 2017
Includes: Supplemental data